New treatment for neuropathic pain

Cassowary Pharma is developing a treatment of neuropathic pain, which is often poorly alleviated by current medications. This builds on research from University of Queensland’s Faculty of Medicine, Faculty of Health and Behavioural Sciences, Faculty of Science and the Australian Institute for Bioengineering and Nanotechnology (AIBN), led by Prof Trent Munro. The CUREator program will support the discovery of new agents suitable for further development.

https://researchers.uq.edu.au/researcher/536